Addressing opioid overdose deaths in the workplace.

Details

• Corporate Authors:
  National Institute for Occupational Safety and Health
• Description:
  On average, 115 Americans die every day from an opioid overdose, according to 2017 data from Centers for Disease Control (CDC). Since then, the United States has experienced a surge of overdose deaths during the 2019 novel coronavirus disease (COVID-19) pandemic, according to a CDC health advisory (https://emergency.cdc.gov/han/2020/han00438.asp) issued in December of 2020. Some states have reported an increase in opioid deaths as high as 98%. Overdoses are becoming increasingly common in the workplace. Naloxone can reverse many of the potentially fatal side effects of an opioid overdose. Having naloxone on hand can provide a tool that a workplace can use while waiting on first responders to arrive on the scene. National Institute for Occupational Safety and Health (NIOSH) developed this video based on our fact sheet (https://www.cdc.gov/niosh/docs/2019-101/default.html) to help employers decide if having naloxone available is right for their workplace. It provides a series of steps for employers to consider when deciding whether their workplaces should make the overdose reversal medication available on-site in the event of an overdose. It also gives employers and workers information on how to implement and maintain a workplace naloxone program. Overdose deaths from opioids is a serious health issues in the United States. Naloxone is an effective drug for reversing opioid overdoses. Consider establishing a naloxone program in your workplace.
• Subjects:
  Accidents, Occupational Aircraft Confined Spaces Occupational Health Paint Preceptorship Safety
• Keywords:
  Drug Therapy Emergency Treatment First Aid Narcotics Pharmaceuticals Total Worker Health TWH
• Publisher:
  National Institute for Occupational Safety and Health
• Document Type:
  Text
• Genre:
  Video
• Place as Subject:
  Georgia ; OSHA Region 4
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  DSI - Division of Science Integration ; OD - Office of the Director
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  5:34 minutes
• NIOSHTIC Number:
  nn:20062328
• Citation:
  Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 2021 Mar; :5:34 minutes
• CAS Registry Number:
  Naloxone (CAS RN 465-65-6)
• Federal Fiscal Year:
  2021
• Peer Reviewed:
  False
• Source Full Name:
  National Institute for Occupational Safety and Health
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:29975f772592880ac9671894fc44f3cd6bd1d4604ef6e463fd341b19e52d6121aee55a405e9f465a7a29df909ec0a57e5ba1221df26f490eb03c5c6bcaaff0b2
• Download URL:
  https://stacks.cdc.gov/view/cdc/181899/cdc_181899_DS1.pdf
• File Type:
  [PDF - 856.56 KB ]